Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
- PMID: 35550680
- PMCID: PMC9050581
- DOI: 10.1016/j.celrep.2022.110829
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant
Abstract
We report that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta spike mutation P681R plays a key role in the Alpha-to-Delta variant replacement during the coronavirus disease 2019 (COVID-19) pandemic. Delta SARS-CoV-2 efficiently outcompetes the Alpha variant in human lung epithelial cells and primary human airway tissues. The Delta spike mutation P681R is located at a furin cleavage site that separates the spike 1 (S1) and S2 subunits. Reverting the P681R mutation to wild-type P681 significantly reduces the replication of the Delta variant to a level lower than the Alpha variant. Mechanistically, the Delta P681R mutation enhances the cleavage of the full-length spike to S1 and S2, which could improve cell-surface-mediated virus entry. In contrast, the Alpha spike also has a mutation at the same amino acid (P681H), but the cleavage of the Alpha spike is reduced compared with the Delta spike. Our results suggest P681R as a key mutation in enhancing Delta-variant replication via increased S1/S2 cleavage.
Keywords: CP: Microbiology; Delta variant; S1/S2 cleavage; SARS-CoV-2; fitness; human airway culture; spike P681R; viral entry.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests X.X., V.D.M., and P.-Y.S. have filed a patent on the reverse genetic system and reporter SARS-CoV-2.
Figures
Update of
-
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.bioRxiv [Preprint]. 2021 Sep 5:2021.08.12.456173. doi: 10.1101/2021.08.12.456173. bioRxiv. 2021. Update in: Cell Rep. 2022 May 17;39(7):110829. doi: 10.1016/j.celrep.2022.110829 PMID: 34462752 Free PMC article. Updated. Preprint.
Similar articles
-
Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant.bioRxiv [Preprint]. 2021 Sep 5:2021.08.12.456173. doi: 10.1101/2021.08.12.456173. bioRxiv. 2021. Update in: Cell Rep. 2022 May 17;39(7):110829. doi: 10.1016/j.celrep.2022.110829 PMID: 34462752 Free PMC article. Updated. Preprint.
-
Spike Protein Cleavage-Activation in the Context of the SARS-CoV-2 P681R Mutation: an Analysis from Its First Appearance in Lineage A.23.1 Identified in Uganda.Microbiol Spectr. 2022 Aug 31;10(4):e0151422. doi: 10.1128/spectrum.01514-22. Epub 2022 Jun 29. Microbiol Spectr. 2022. PMID: 35766497 Free PMC article.
-
The Spike-Stabilizing D614G Mutation Interacts with S1/S2 Cleavage Site Mutations To Promote the Infectious Potential of SARS-CoV-2 Variants.J Virol. 2022 Oct 12;96(19):e0130122. doi: 10.1128/jvi.01301-22. Epub 2022 Sep 19. J Virol. 2022. PMID: 36121299 Free PMC article.
-
Proteolytic activation of SARS-CoV-2 spike protein.Microbiol Immunol. 2022 Jan;66(1):15-23. doi: 10.1111/1348-0421.12945. Epub 2021 Oct 12. Microbiol Immunol. 2022. PMID: 34561887 Free PMC article. Review.
-
Delta variant (B.1.617.2) of SARS-CoV-2: Mutations, impact, challenges and possible solutions.Hum Vaccin Immunother. 2022 Nov 30;18(5):2068883. doi: 10.1080/21645515.2022.2068883. Epub 2022 May 4. Hum Vaccin Immunother. 2022. PMID: 35507895 Free PMC article. Review.
Cited by
-
COVID-19 Genomic Surveillance in Bangui (Central African Republic) Reveals a Landscape of Circulating Variants Linked to Validated Antiviral Targets of SARS-CoV-2 Proteome.Viruses. 2023 Nov 24;15(12):2309. doi: 10.3390/v15122309. Viruses. 2023. PMID: 38140550 Free PMC article.
-
Genomic and Phylogenetic Characterisation of SARS-CoV-2 Genomes Isolated in Patients from Lambayeque Region, Peru.Trop Med Infect Dis. 2024 Feb 11;9(2):46. doi: 10.3390/tropicalmed9020046. Trop Med Infect Dis. 2024. PMID: 38393135 Free PMC article.
-
SARS-CoV-2 and innate immunity: the good, the bad, and the "goldilocks".Cell Mol Immunol. 2024 Feb;21(2):171-183. doi: 10.1038/s41423-023-01104-y. Epub 2023 Nov 20. Cell Mol Immunol. 2024. PMID: 37985854 Free PMC article. Review.
-
Insight into SARS-CoV-2 Omicron variant immune escape possibility and variant independent potential therapeutic opportunities.Heliyon. 2023 Feb;9(2):e13285. doi: 10.1016/j.heliyon.2023.e13285. Epub 2023 Jan 31. Heliyon. 2023. PMID: 36744070 Free PMC article. Review.
-
SARS-CoV-2: Evolution and Emergence of New Viral Variants.Viruses. 2022 Mar 22;14(4):653. doi: 10.3390/v14040653. Viruses. 2022. PMID: 35458383 Free PMC article. Review.
References
-
- Andersen C. 2019. Catseyes: Create Catseye Plots Illustrating the Normal Distribution of the Means. R package version 0.2.3.
-
- Bergren N.A., Haller S., Rossi S.L., Seymour R.L., Huang J., Miller A.L., Bowen R.A., Hartman D.A., Brault A.C., Weaver S.C. "Submergence" of Western equine encephalitis virus: evidence of positive selection argues against genetic drift and fitness reductions. PLoS Pathog. 2020;16:e1008102. doi: 10.1371/journal.ppat.1008102. - DOI - PMC - PubMed
-
- Brown C.M., Vostok J., Johnson H., Burns M., Gharpure R., Sami S., Sabo R.T., Hall N., Foreman A., Schubert P.L., et al. Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings — Barnstable county, Massachusetts, July 2021. MMWR Morb. Mortal. Wkly. Rep. 2021;70:1059–1062. https://www.cdc.gov/mmwr/volumes/70/wr/mm7031e7032.htm?s_cid=mm7031e7032... - PMC - PubMed
-
- CDC COVID data tracker. 2021. https://covid.cdc.gov/covid-data-tracker/#variant-proportions
-
- Chen R.E., Zhang X., Case J.B., Winkler E.S., Liu Y., VanBlargan L.A., Liu J., Errico J.M., Xie X., Suryadevara N., et al. Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. 2021;27:717–726. doi: 10.1038/s41591-021-01294-w. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
